Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Giredestrant for estrogen receptor-positive, HER2negative, previously treated advanced breast cancer: results from the randomized, phase II acelERA breast cancer study
Albulushi A, et al
Timothy Caulfield, a law professor at the University of Alberta, said that health influencers increasingly engage in scienceploitation: they generate hype by making speculative claims that extrapolate wildly from limited research
One of the limitations of BBB models prepared from stem cell derived vascular endothelial cells is to induce appropriate barrier tightness and BBB characteristics
Its more applicable for chronic inflammatory or autoimmune conditions
As of early 2026, cagrilintide is not FDA approved as a standalone medication
US$ 29.23
US$ 28.47
US$ 28.79
